Methoxychlor is carcinogenic for the liver of C3H and BALB/c mice and Osborne-Mendel rats, and possibly for the liver of dogs. Methoxychlor is also carcinogenic for the testis of BALB/c male mice, bone of B6C3F1 female mice, and the ovary of Osborne-Mendel female rats. The incidences of carcinomas of the liver were increased in C3H male mice and BALB/c male and female mice fed methoxychlor. There also was an increase in malignant neoplasms at all sites in BALB/c male and female mice. C3H and BALB/c male mice were more susceptible to the carcinogenic effects of methoxychlor than were female mice. BALB/c mice were more susceptible than C3H mice. Osborne-Mendel male and female rats developed significant incidences of carcinomas of the liver. The incidence of sarcomas of the spleen and abdomen, mostly hemangiosarcomas, was increased in male rats. Neoplasms of the pituitary, adrenals, and mammary gland were also increased in methoxychlor-treated female rats. Miniature swine given methoxychlor developed chronic renal disease in relatively short periods of time. There also was hyperplasia of the mammary gland and uterus, suggesting an estrogen-like effect on those organs. Methoxychlor applied to the skin of rabbits caused a dose-related atrophy of the testes, as well as chronic renal disease. Atrophy of the testes and chronic renal disease could not be evaluated in mice and rats because of insufficient data.
Introduction
Methoxychlor [1,1'-(2,2,2-trichloroethylidene) bis (4-methoxy) benzene], also known as dianisyltrichlorethane, dimethoxy DDT, and DMDT, is a structural analog of DDT. It is used against a wide range of insects that attack fruits, vegetables, shade trees, home gardens, forage crops, and livestock. Methoxychlor is also used for the spray treatment of barns, grain storage bins, mushroom houses, dairies, and other agricultural buildings. Since methoxychlor is relatively ineffective against soil organisms, it is generally applied directly to crops by ground or aerial spraying. This review includes, to the best of our knowledge, every study on the carcinogenicity of methoxychlor in animals. The results and conclusions are based upon my examination of the raw data and, whenever possible, of the histological sections. The histological sections were BALB/c (BALB/cJ) and C3H (C3HeB/FeJ) strains male and female mice ingested 750 ppm technical methoxychlor (1, 2) . Mice, 3 weeks of age, were given the pesticide in ground laboratory meal for periods up to 2 years. There were 100 mice of each strain and sex given methoxychlor, as well as 100 controls of each sex. Tissues from all mice with lesions, as well as tissues from many grossly normal mice, were fixed in 10% formalin. Hematoxylin and eosin stained paraffin sections were prepared from all gross lesions in which tumors were suspected and from tissues with incidental gross lesions. The procedures have been described (3) .
BALB/c male mice ingesting methoxychlor survived for an average of 80.8 weeks (55-104), and controls for 94.8 weeks (60-104) ( Table 1) . Females given methoxychlor survived for 95.4 weeks (59-104), compared to 96.2 weeks (59-104) for controls.
C3H male mice receiving methoxychlor survived for an average of 99.4 weeks (71-104), and control mice for 101.4 weeks (89-104) ( Table 2 ). The survival of methoxychlor-treated female mice did not differ from that of control female mice.
Carcinomas of the Testis
Carcinomas of the testis were observed in BALB/c male mice ingesting methoxychlor, as well as in a small number of control mice (Table  3) . C3H male mice ingesting methoxychlor did not develop tumors of the testis.
Carcinomas of the testis were present in 27 of 51 BALB/c male mice (53%) ingesting methoxychlor compared to 8 of 71 control male mice (11%) (p = 0.000,000,6). Tumors of the testis were more malignant in methoxychlor-treated mice than in the control mice. They were observed at an earlier age (an average of 87.5 weeks for treated and 103.8 weeks for controls); were larger in size (carcinomas were large in treated mice; whereas three of the seven carcinomas in controls were 2-4 mm in size); were less differentiated histologically; and were more invasive in methoxychlortreated mice than in control mice. They also occasionally were bilateral in treated mice. One treated mouse had a metastasis to a lymph node adjacent to the left adrenal, which was seen grossly. The incidence of metastases is not reliable unless serial sections of lymph nodes and other organs are examined histologically, which was not the case in this study.
Neoplasms of the Liver C3H Mice. Male C3H mice ingesting methoxychlor were more susceptible to the development of carcinomas of the liver than were female mice. Carcinomas of the liver were present in 43 of 92 C3H male mice (47%) (p = 0.00088) and 15 of the 83 female mice (18%) ingesting methoxychlor; whereas 23 of 96 control male mice (24%) and 11 of 99 control female mice (11%) developed hepatocellular carcinomas (Table 4) .
There was occasionally more than one carci-206 noma of the liver measuring 3-5 cm in diameter in mice given the pesticide in the diet. By contrast, the carcinomas in control mice were solitary. There were metastases in the lungs of one male mouse ingesting methoxychlor and two control male mice. Table 6 ).
The neoplasms were predominantly carcinomas in treated male and control male mice; whereas female mice had both carcinomas and sarcomas.
Sarcomas metastasized in 3 male mice (4%) and 4 female mice (4%) given methoxychlor, compared to 0 in the control mice. Carcinomas in male mice receiving methoxychlor in the diet developed in the liver, testis, and lung. Sarcomas of the uterus and liver were observed in female mice given methoxychlor.
Summary
Methoxychlor is carcinogenic for the liver of C3H and BALB/c male mice and BALB/c female mice and for the testis of BALB/c male mice. There also was an increase in malignant neoplasms at all sites in BALB/c male and female mice. C3H and BALB/c male mice were more susceptible to the carcinogenic effects of methoxychlor than were female mice. BALB/c mice were more susceptible than C3H mice.
FDA Methoxychlor Rat Study
Osborne-Mendel strain male and female rats, 21 days of age, 12 per group, were used (4). Littermates were selected at random for the test and control groups. Rats were housed individually and were allowed food and water ad libitum. Technical methoxychlor was dissolved in 1% corn oil and incorporated into ground commercial laboratory meal in a food mixer. Rats ingested dietary levels Histological sections from 19 rats included lung, heart, liver, spleen, pancreas, stomach, small intestine, colon, kidney, adrenal, thyroid, testis, uterus, ovary, leg muscle, leg bone, and bone marrow. In the other 80 rats, sections were made of liver, kidney, and testis.
Neoplasms of the Liver in Female Rats
Carcinomas were present in the liver of treated females. Three of nine female rats (33%) ingesting 2000 ppm had carcinomas compared to 0% control female rats; and an additional rat had a hyperplastic nodule, which increased the incidence of hepatic neoplasms to 44% in female rats given 2000 ppm methoxychlor (p = 0.04118) ( Table 7) . Ten of 52 treated female rats (19%) had hyperplastic nodules or carcinomas of the liver. This incidence is significant when compared with the usual 1 of 50 neoplasms of the liver observed in control rats in this laboratory (FDA) (p = 0.00478). All but one of the neoplasms were found in the survivors.
Female rats ingesting methoxychlor developed severe diffuse hyperplasia of the liver which generally was 2-3+ in rats given 25 ppm and increased to 5+ in rats receiving 2000 ppm methoxychlor. Hyperplasia was 0-1+ in control rats. 
Neoplasms of the Liver in Male Rats
Carcinomas of the liver were observed in three of eight male rats (38%) ingesting 2000 ppm methoxychlor and in 0% controls (Table 8 ). An additional treated rat had a hyperplastic nodule, increasing the incidence of hepatic neoplasms to 50%. Eight of 32 male rats (25%) given methoxychlor developed hyperplastic nodules and carcinomas of the liver; whereas 0% were observed in control male rats. This incidence is significant when compared to the usual 1 of 50 neoplasms of the liver generally observed in this laboratory (FDA) (p = 0.00189).
Control rats had hyperplasia that was 0-1+, and treated male rats had severe diffuse hyperplasia which increased from 2-3+ in rats given 25 ppm methoxychlor to 5+ in rats given 200, 500, or 2000 ppm.
Carcinomas of the Ovary in Female Rats
Five of 10 female rats (50%) ingesting 500 ppm and 1 of 10 (10%) given 100 ppm developed carcinomas of the ovary. There were small carcinomas in rats given 500 ppm. The one in the female given 100 ppm was a large carcinoma, measuring several centimeters in diameter. When ovarian tumors are included, the incidence of carcinomas in female rats given 500 ppm increased from 20% to 70% (p = 0.0099) and the incidence of malignant tumors to 90% ( Table 9 ). The incidence of carcinomas of the ovary is significant when compared to 0 of 10 control rats (p = 0.01625) and also when compared to 0 to 50 observed in control rats in this laboratory (FDA) (p = 0.00005).
Malignant Neoplasms in Other Organs
Malignant neoplasms present in other organs in methoxychlor-treated and untreated female rats were carcinomas of the mammary gland or lymphosarcomas, generally of the lung. Lymphosarcomas also were present in male rats.
Summary and Conclusions
Male and female rats developed significant incidences of hepatocellular carcinomas of the liver. Carcinomas of the ovary were also significantly increased in treated female rats. Methoxychlortreated male and female rats also had severe diffuse hyperplasia of the liver.
Methoxychlor is carcinogenic for the liver in male and female Osborne-Mendel rats and for the ovary of Osborne-Mendel female rats.
FDA Methoxychlor Dog Study
One male and three female dogs were fed 300 mg/kg/day of methoxychlor for 3.5 years (5) . Methoxychlor was given in capsules as a 10% solution in corn oil.
Two dogs died after 105 and 260 days. One of those was a female dog that had tremors after the beginning and before the end of the treatment. The cause of death was probably acute pneumonia. The second dog, a male, had hemorrhage The foci observed on gross examination were small hepatocellular carcinomas of the liver. There also was a small number of hepatic cells with foamy cytoplasm around central veins in the same dog. In the second dog, which was described as "negative" grossly, there was "slight fibrosis, with fibrotic areas containing macrophages with yellowish pigment, new blood vessels, and small bile duct-like structures." Fat stains disclosed a small amount of fat in the livers.
The adrenals in both dogs had slightly ballooned cells in the zona fasciculata, in which increased fat was demonstrated. The nodule in the spleen was lymphoid tissue. There was increased fat in the outer cortex of the kidney in 1 dog and chronic cholecystitis in both dogs.
In summary, one female dog given methoxychlor in the diet for 3.5 years developed carcinoma of the liver; another had fibrosis of the liver.
There also was increased lipid in the adrenal glands.
FDA Methoxychlor Miniature Male and Female Swine Study
Twenty-eight miniature swine, 6.5-23.5 months old were started on a study in which methoxychlor was added to the feed at a daily dosage level of 1 g/kg body weight (6) . The 28 swine were divided into the following groups: three spayed gilts, four boars, four sows, and seven gilts bred prior to test, four sows and four gilts started on test and then bred (one gilt did not come into heat), one gilt started on test at the time of farrowing, and one bred gilt sacrificed as a control.
At periods from 4-12 weeks on test the dosage level was increased to 2 g/kg body weight in four sows and three gilts. One control was also given 1 g/kg after she had farrowed.
The three spayed gilts exhibited signs of continuous heat after 21 days on methoxychlor and 1 also had a prolapsed vagina. Female piglets from three animals developed swollen vulvas and showed signs of heat. Eight females started on test before breeding had moderate hyperplasia of the mammary gland with milk-like secretion prior Table 9 . Number of female rats ingesting methoxychlor with malignant neoplasms (FDA rat study). November 1980 209 to breeding or pregnancy; six of the eight showed signs of pseudocyesis, one failed to come into heat, and one conceived and farrowed. Changes were not observed in the four male swine.
Histological examination was done on brain, thyroid, liver, pancreas, spleen, kidney, adrenal, testis, uterus, ovary, and mammary gland. In addition, the pituitary, heart, lung, thymus, spinal cord, small intestine, colon, and male accessory glands were examined from several pigs. Six testes from castrated boars were used as controls.
Two animals died after periods of 10 and 17 weeks of test. The sow that died after 10 weeks had severe hemorrhage and necrosis of the gastrointestinal tract. The remaining 25 swine given methoxychlor in the feed were killed at periods varying from 6-40 weeks.
Lesions Observed on Gross Examination
Severe fibrotic lesions or scarring of the kidneys was seen consistently in all animals given methoxychlor in the feed. Cysts were present in the uteri of the three spayed gilts. Two females that had farrowed and four that did not conceive had edematous uteri. There were cysts in the mesosalpinx or mesovarium in four females. Two of the four boars had small testes.
Liver changes were described as yellowish and reticulated in a pregnant sow and as light brown and hard in a gilt that had farrowed. Ascites was present in one boar and in one sow that had farrowed.
Renal and Hepatic Disease
Chronic interstitial fibrosis was present in all pigs given methoxychlor. There 
FDA Methoxychlor Rabbit Study
Methoxychlor was applied to the skin, 30% in dimethyl phthalate, of male and female rabbits (9) . The doses were 0.5, 1.0, 2.0, or 4.0 ml/kg/day, 5 days a week, over a 109-day period (78 applications). There were two males and one female in each group, with the exception of three male rabbits given the 2.0 ml dose. Complete necropsies were done on male rabbits given the 2.0 or 4.0 ml doses, except for one given 4.0 ml because of advanced autolysis. The heart, liver, gallbladder, kidney, testes, uterus, ovary, skin, and bone marrow were examined histologically in the remaining six rabbits. A Giemsa-stained smear of bone marrow was studied for every rabbit.
Rabbits receiving methoxychlor developed severe anorexia, depression, and emaciation; one male rabbit receiving 4.0 ml/kg/day was dead after 10 days and one female died after 28 days. The following changes were observed in the male rabbit: slight atrophy of liver, spleen, muscle and pancreas; moderate atrophy of skin appendages and marrow; severe atrophy of testes; edema of the wall of the gallbladder; slight to moderate hyperkeratosis; and slight thickening of the stratus spinogum of the skin.
One male rabbit given 2.0 ml/kg/day methoxychlor was markedly emaciated and moribund and was killed after 10 days. The rabbit had moderate atrophy of the liver, spleen, bone marrow, testes, and pancreas.
The remaining nine rabbits survived for the duration of the study. The male rabbit given 4.0 ml/ kg/day was markedly emaciated; the rabbits given the other doses were slightly to moderately emaciated.
Skin Lesions
The skins of all the surviving rabbits were slightly rough with a small or moderate amount of whitish branny scaling. "Hyperkeratosis was moderate, or slight to moderate; thickening of the stratum spinosum of the epidermis was either slight or slight to moderate; infiltration of the subepidermal corium with chiefly mononuclear cells varied from almost none to a small amount. No ulceration of the skin was seen."
Chronic Renal Disease
The male rabbit given 4.0 ml/kg/day methoxychlor had kidneys which were double the normal size and were slightly pale, fibrous and granular, and the testes were markedly atrophic. There was slight portal fibrosis, cellular infiltration and atrophy of the liver. The chronic interstitial fibrosis was severe. One female given 1.0 ml/kg/day and one male receiving 2.0 ml/kg/day had focal nephritis.
"The cortex and outer medulla are diffusely damaged to a moderate degree; the damage consists of narrow bands or groups of dilated, enlarged or atrophic tubules mixed with other small groups or bands of tubules which appear normal except for perhaps some compensatory hypertrophy. Such glomerular atrophy or other glomerular damage as is present appears to be secondary to the tubular damages in the same locality. Intermingled with the atrophic tubules is a moderate amount of loose fibrous tissue and a relatively small amount of chronic inflammatory cellular exudate" (9) .
Atrophy of the Testes
Atrophy of the testes was proportional to the dosage of methoxychlor and was present in all surviving rabbits (7 of 7 rabbits). The atrophy was severe in rabbits given 2.0 or 4.0 ml/kg/day, moderate in those receiving 1.0 ml/kg/day, and slight in one rabbit at the lowest dose; the remaining rabbit at the lowest dose had focal marked atrophy. There was marked atrophy in the rabbit receiving the highest dose for only 10 days. Atrophy was not described in the rabbits given 2.0 ml/kg/day for a 15-day period.
Lesions of the Bone Marrow
There was reduction in the number of mature granulocytes of the bone marrow in a male rabbit given 2.0 ml/kg/day. The marrow was slightly hyperplastic in a male given the highest dose, and another male receiving 1.0 ml/kg/day. The marrow was hyperplastic in one male and one female at the 0.5 ml dose.
Summary
Methoxychlor applied to the skin over a period of 109 days caused atrophy of the testes in male rabbits. The degree of atrophy was related to the dose, i.e., severe at the two highest doses and moderate at the lower doses. The one surviving rabbit receiving the highest dose developed severe chronic interstitial fibrosis of the kidney. Changes were also observed in the skin and bone marrow.
NCI Methoxychlor Rat Study
Osborne-Mendel male and female rats, 44 days of age, were given methoxychlor at two dose levels in the diet (10) . There were 50 treated rats in each group, and 20 control rats of each sex.
212
Male rats ingested an average of 442 or 845 ppm for 78 weeks. Female rats ingested an average of 845 or 1385 ppm (Table 10) . Rats were killed after 111 weeks.
The life span of rats ingesting methoxychlor was shortened, particularly those receiving the low dose (Table 11) .
Sarcomas in Male Rats
There was an increase in sarcomas in male rats ingesting methoxychlor (Table 12 ). Most of the sarcomas were hemangiosarcomas and they occurred in the spleen and abdomen. There were more sarcomas of the spleen (19%) in male rats given the low dose. There were more sarcomas of the abdomen (10%) in male rats receiving the high dose or methoxychlor.
Neoplasms of the Pituitary
Female rats given the high dose of methoxychlor had over two times as many adenomas and carcinomas of the pituitary (43%) (p = 0.067) compared to the controls (20%) ( Table 13 ). The neoplasms were dose-related (p = 0.038).
Neoplasms of the Adrenal Gland
Carcinomas of the adrenal gland, as well as both adenomas and carcinomas, were increased in female rats given the low or high doses of methoxychlor (Table 14) . Benign and malignant neoplasms were observed in 15% of the controls, in 30% of the rats on the low dose, and 38% of the rats on the high dose.
Neoplasms of the Ovary
Carcinomas of the ovary were present in 0 of 20 control female rats (0%), 5 of 46 female rats (11%) given the low dose, and 11 of 47 female rats (23%) (p = 0.014) receiving the high dose of methoxychlor (Table 15) . Neoplasms of the ovary were dose-related (p = 0.0034). (Tables 18 and 19) . Furthermore, the incidence of benign and malignant neoplasms in control rats was so high that differences between the controls and methoxychlortreated rats could not be detected. This high incidence in control rats strongly suggests contamination of those rats with methoxychlor.
There were some positive findings despite these shortcomings.
Hepatic vein thrombi, seen in mice receiving dieldrin, aldrin, heptachlor, or heptachlor epoxide, were rarely seen in Osborne-Mendel rats given dieldrin or aldrin (11, 12 (Table 20) . Mice were killed after 92 weeks.
Some male mice given the low or high dose of methoxychlor died early, as did some control male mice (Table 21) .
Examinations of male and female mice ingesting methoxychlor, particularly female mice, were not adequate (Tables 22 and 23 ). The 19 male mice on the high dose and 17 male mice on the low dose of methoxychlor were not examined histologically, although some may have been examined grossly. Eleven low dose male mice were dis- November 1980 (Table 25) . By contrast, 0 of 20 control male mice (0%) and 1 of 17 control female mice (6%) developed sarcomas of the bone.
Lesions Other Than Neoplasms
Three of 36 male mice (8%) given the low dose of methoxychlor developed thrombosis of the atria of the heart. B6C3F1 male mice, both untreated and treated, in this laboratory (Hazelton) developed chronic renal disease and amyloidosis of the kidney and spleen, as well as liver; whereas they did not in some other laboratories (Table 26 ).
Comments
Hemangiosarcomas of the vertebra were strikingly increased in female mice receiving methoxychlor. Such incomplete histopathological examinations do not make it possible to reach conclusions concerning the carcinogenicity of methoxychlor for other organs of mice. Neoplasms of the liver, as well as in other organs, might well be overlooked. There was, however, a slightly increased incidence of malignant neoplasms in female mice given the low dose.
The doses of methoxychlor were toxic and killed many of the mice. The small number of histological sections of spleen and lymph nodes suggested that at least some mice may have developed malignant lymphomas if they had lived for a long enough period of time. There also were severe chronic renal disease, particularly in the male mice (Table 26) .
B6C3F1 female mice given chloroform developed a significant incidence of thrombosis in the atria of the heart (13).
C3H mice are more susceptible to the induction of hepatic neoplasms by the chlorinated hydrocarbons and should be used rather than B6C3F (14, 15 ).
Summary
Methoxychlor is carcinogenic for bone of female B6C3F1 mice. There was also a significantly (16) . They were 2-4 months old at the beginning of the treatment. They were given Purina laboratory chow. Methoxychlor was dissolved in trioctanoin (0.05% and 5.0%).
Mice were examined weekly. They were observed until death, at which time the carcass was placed in formalin. Gross necropsy was done later and, if autolysis had not occurred, sections of the skin were taken for histological study.
Subcutaneous
Single subcutaneous injections of 0.02 ml were made in the midscapular region. The mean survival time varied from 372-419 days.
Many mice died with pneumonitis. Neoplasms were not observed in these mice; however, newborn or young mice are preferable for single subcutaneous injection studies rather than mice 2-4 months of age.
Skin Painting
Mice were shaved with an electric clipper and their hair removed from an area approximately 3 Two dogs, sex not given, were each fed 0, 20, 100, or 300 mg/kg/day of methoxychlor for 1 year (17) . One female given 100 mg/kg died after 9 months with severe stomach ulcers. Another female dog given 20 mg/kg died after 11 months following an acute illness resembling distemper.
Histological examination was done for heart, lungs, spleen, stomach, large and small intestine, liver, adrenal, kidney, bladder, lymph node, bone marrow, and brain.
Two dogs given 20 mg/kg and the 2 dogs given 300 mg/kg developed hyperplastic lymphoid and marrow tissue and pyelonephritis and granulomas of the kidney, as did 1 control dog. The dog given 150 mg/kg/day for 1 year had acute and chronic cholangitis. One dog receiving 300/mg/kg had mesenteric adenitis.
Summary
Small numbers of dogs were used in this study of limited duration. Dogs given methoxychlor did die and did develop diseases, i.e., cholangitis, mesenteric adenitis, and stomach ulcers, which were not seen in the control dogs.
Methoxychlor Study of Haag et al.
Male and female albino rats about 30 days old and 7 in each group were used. Rats ingested 0, 31 31 300, 600, 900, 1200, 2500, 5000, or 10000 ppm of methoxychlor (recrystallized) in ground Purina dog chow for periods up to 1 year (18) . Histological examinations on selected rats were done for heart, lungs, gastrointestinal tract, liver, spleen, kidney, adrenal, pancreas, thyroid, gonads, skeletal muscle, and skin. In some cases, bone marrow and brain were examined. Examinations were done on 7 rats at 1000 ppm, 7 rats at 5000 ppm, 1 at 2500 ppm, and 1 at 600 ppm. Female rats ingesting 10000 ppm methoxychlor became emaciated and died within 10 weeks. Male and female rats given the other doses of methoxychlor survived about as well as the control rats. Retarded growth was observed in males and females given 2500 ppm. Lymphosarcomas were found in 1 rat given 2500 ppm and 1 rat receiving 600 ppm methoxychlor. Urinary bladder 20 16 21 Bone marrow 20 18 20 Lymph nodes Small numbers of rats were used in this study. Histological examinations were limited. Results were not separated by sex.
Methoxychlor Rat Study of Radomsky et al.
Methoxychlor
Methoxychlor, 80 ppm, was added to Purina laboratory chow supplemented with 1% cod liver oil (19) . The diet was ingested by Osborne-Mendel weanling male and female rats, 30 in each group, for 2 years. Control rats were given the diet without the pesticide. All rats which died or were killed were examined for the presence of tumors. Tumors were examined histologically.
Treated rats did not have more tumors than the control rats; however, control rats developed a high incidence of tumors, particularly mammary gland. In addition, histological examinations were incomplete.
Methoxychlor Plus Other Pesticides
A mixture of 50 ppm of each of methoxychlor, DDT, aramite, and thiourea was ingested by 50 rats of each sex under comparable conditions (given above). Groups of rats were not given the individual pesticides by themselves.
Six of 50 control female rats (12%) had hepatic tumors compared to 9 of 49 female rats (18%)
given the mixture. Tumors of the liver were observed in 1 of 50 male control rats (2%) and 10 of 50 male rats (20%) ingesting the mixture of pesticides (p = 0.0039).
Another mixture of 80 ppm of each pesticide rats (20%) ingesting 1600 ppm, one of seven female rats (14%) given 200 ppm, and two of ten female rats (20%) given 25 ppm developed neoplasms, whereas zero of eight male and five female control rats had neoplasms. A total of seven of 28 female rats (25%) ingesting methoxychlor had neoplasms. There were six surviving male rats, three receiving 25 ppm and three given 200 ppm methoxychlor, that did not develop neoplasms.
The neoplasms in the female rats ingesting 1600 ppm methoxychlor were cystadenoma of the ovary, neoplasms of the abdominal wall, adenocarcinoma of the pancreas, and epidermoid carcinoma. There was a mammary neoplasm in a female rat given 200 ppm and neurofibroma and lung neoplasms in the female rats receiving 25 ppm. One male rat given 1600 ppm had a mammary tumor.
The authors stated that: "One of the most frequent causes of death during the second year in our rats is cancer. The large number of tumors in the 0.16% group of females is believed to be coincidental." However, the data concerning neoplasms developing in rats in this study during the second year were not given.
The results of the study suggest that methoxychlor is carcinogenic, particularly for female rats. An unusual neoplasm, adenocarcinoma of the pancreas, was present in a treated female rat. Since additional data concerning all rats that died or were killed before the end of two years is unavailable, conclusions cannot be made from this study. (20) .
The liver, heart, lung, brain, pituitary, kidney, spleen, pancreas, stomach, small intestine, and testes or ovary, as well as all tumors, were examined histologically.
The weight of the rats ingesting methoxychlor remained the same during the second year. At the end of 24 months, 43% of the male rats and 37% of the female rats given methoxychlor were living compared to 50% and 60% of the control rats.
Five of 28 male rats (18%) ingesting methoxychlor developed neoplasms, compared to 1 of 28 control male rats (4%). Data concerning the location or the number of malignant neoplasms are not given for these rats. Many of the neoplasms in female rats were mammary gland.
There was hydropic change, fatty change, and focal centrolobular necrosis in the liver and hemosiderin in the spleen of methoxychlor-treated rats.
There was an increased incidence of neoplasms in male rats ingesting methoxychlor; however, the data given are incomplete and conclusions cannot be made concerning the effects of methoxychlor.
Comments
BALB/c strain male mice ingesting methoxychlor developed a highly significant incidence of interstitial cell carcinomas of the testes. Since BALB/c strain male mice treated with estrogens readily develop carcinomas of the testis, the carcinogenicity of methoxychlor for testis is most likely related to its estrogenic activity (2) . Methoxychlor was estrogenic for the mammary gland and uterus in swine in the FDA studies (6) (7) (8) .
The estrogenic activity of methoxychlor, DDT, and other analogs has been established. There are some structural similarities between these compounds and diethylstilbestrol (21) . Technical methoxychlor stimulated uterine growth in mice and rats (22) ; caused atrophy and abnormal development of the testis of young male-rats (23, 24) ; interfered with reproduction in rats (25) ; and interfered with the in vivo uptake of estradiol by the rat uterus (26, 27) .
DDT, the structural analog of methoxychlor, is carcinogenic for the liver of mice and rats and for the ovary of rats (28) (29) (30) (31) (32) (33) (34) (35) .
The formation and occurrence of tumors in all mammals is quite similar. Virtually every chemical which has been found to be carcinogenic in humans is also carcinogenic in one or more other mammalian test animals (36) . It has been demonstrated that if a chemical will produce neoplasms in any one species, it will likely produce neoplasms in another. We strongly feel that a finding of carcinogenicity in one mammalian species is therefore relevant to all mammals, including humans. This threat may not be manifested for up to 30 or 40 years, given the long latent period of many known human carcinogens. Given the state of carcinogenicity testing and knowledge, there can be only one safe tolerance for a carcinogenan absolute zero tolerance-and the only way a substance shown to be carcinogenic in test animals will not be a threat to human health is simply to prevent that substance from entering the environment. To the extent that it does enter man's environment, it will constitute a very real threat to his health.
The carcinogenicity of methoxychlor was reviewed at the IARC. They concluded that "the available data did not provide evidence that methoxychlor is carcinogenic in animals."
Interpretation of carcinogenicity studies varies with the reviewer. Problems are often found with the incomplete presentation and analysis of the data, as well as with different diagnoses by pathologists (37) . The IARC monograph did not include the FDA mouse and rat studies on methoxychlor because "...., only reports that have been published or accepted for publication are reviewed by the working groups, ...." (38) .
